EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Long-term SBP time in target and risk of cardiovascular events in older adults: a secondary analysis of the ASPREE cohort

Michael E Ernst iD, Katherine L Webb iD, Raj C Shah iD, Lawrence Beilin, Alice Owen iD, Suzanne G Orchard, Michelle A Fravel, Robyn L Woods iD, Mark R Nelson, Kevan R Polkinghorne, Nigel Stocks, Rory Wolfe iD und 2 weitere

American Journal of Hypertension · 2026

DOI: 10.1093/ajh/hpag070 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift American Journal of Hypertension, 2026. Verfasst von Michael E Ernst und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice and Science, College of Pharmacy, The University of Iowa, Iowa City, IA, United States. Hauptthemen laut MEDLINE: Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Hypertension. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIH HHS, Victorian Cancer Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

BP time in target range (TTR) predicts cardiovascular disease (CVD) in high-risk populations; however, TTR’s predictive utility in older adults without prior CVD is uncertain.

Methods

We performed a post hoc analysis of the ASPirin in Reducing Events in the Elderly trial and its observational follow-up. SBP TTR for <140 and <130 mm Hg was estimated for each participant using BPs from the first 3 visits. Participants with 0% or 100% TTR were categorized separately, and remaining participants grouped into tertiles using linear interpolation to estimate TTR. Cox proportional hazards models evaluated associations between TTR and adjudicated incident CVD and major adverse cardiovascular events (MACE) after the TTR estimation period, with 0% TTR as reference.

Results

Among 16,730 predominantly White Australian adults (mean age, 74 years) followed for a mean of 7.7 years after TTR estimation, 100% TTR <140 mm Hg had reduced risk of CVD (HR, 0.81; 95% CI, 0.68-0.96; P = .01), while 100% TTR <130 mm Hg had reduced risks of CVD (HR, 0.82; 95% CI, 0.67-0.99; P = .04) and MACE (HR, 0.72; 95% CI, 0.57-0.91; P < .01). Associations were strongest among women, antihypertensive users, frail/pre-frail participants, and those younger than median age. Findings were consistent after adjusting for competing risk of non-CVD death, when the TTR estimation period was extended an additional year, and when estimated using proportion of individual visit BPs at target.

Conclusions

Longer SBP TTR was associated with reduced risk of cardiovascular events in older adults, underscoring the importance of sustained BP control with aging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsBlood PressureCardiovascular DiseasesHypertensionAgedAged, 80 and overFemaleHumansMaleAge FactorsAspirinAustraliaIncidenceRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

blood pressurecardiovascular eventshypertensionolder adultssystolic blood pressuretime in target

Substanzen

Antihypertensive AgentsAspirin

Autor:innen und Institutionen

  • Department of Pharmacy Practice and Science, College of Pharmacy, The University of Iowa, Iowa City, IA, United States.
  • Department of Family and Community Medicine, Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Department of Family and Preventive Medicine and the Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, United States.
  • Medical School Royal Perth Hospital, University of Western Australia, Perth, WA, Australia.
  • Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.

ORCID-Profile: Michael E Ernst, Katherine L Webb, Raj C Shah, Alice Owen, Robyn L Woods, Rory Wolfe, Jordana B Cohen, Christopher M Reid

Förderung

  • NIA NIH HHS
  • NIH HHS
  • Victorian Cancer Agency
  • National Health and Medical Research Council of Australia
  • The ASPirin in Reducing Events in the Elderly
  • NCI NIH HHS
  • NIA
  • NCI

Zitieren

APA

Ernst, M. E., Webb, K. L., Shah, R. C., Beilin, L., Owen, A., Orchard, S. G., Fravel, M. A., Woods, R. L., Nelson, M. R., Polkinghorne, K. R., Stocks, N., Wolfe, R., Cohen, J. B., & Reid, C. M. (2026). Long-term SBP time in target and risk of cardiovascular events in older adults: a secondary analysis of the ASPREE cohort. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpag070

Vancouver

Ernst ME, Webb KL, Shah RC, Beilin L, Owen A, Orchard SG, et al. Long-term SBP time in target and risk of cardiovascular events in older adults: a secondary analysis of the ASPREE cohort. American Journal of Hypertension. 2026. doi:10.1093/ajh/hpag070

BibTeX
@article{Ernst2026,
  author = {Ernst, Michael E and Webb, Katherine L and Shah, Raj C and Beilin, Lawrence and Owen, Alice and Orchard, Suzanne G and Fravel, Michelle A and Woods, Robyn L and Nelson, Mark R and Polkinghorne, Kevan R and Stocks, Nigel and Wolfe, Rory and Cohen, Jordana B and Reid, Christopher M},
  title = {Long-term SBP time in target and risk of cardiovascular events in older adults: a secondary analysis of the ASPREE cohort},
  journal = {American Journal of Hypertension},
  year = {2026},
  doi = {10.1093/ajh/hpag070}
}
Kostenlos starten →